Your browser doesn't support javascript.
loading
Editing of DNA methylation using CRISPR/Cas9 and a ssDNA template in human cells.
Katayama, Shota; Andou, Masao.
Afiliación
  • Katayama S; IMRA Japan Co., Ltd., Sapporo, 004-0015, Japan; AISIN Co., Ltd., 2-1 Asahi-cho, Kariya, 448-8650, Japan. Electronic address: shota.katayama@imra-japan.com.
  • Andou M; IMRA Japan Co., Ltd., Sapporo, 004-0015, Japan.
Biochem Biophys Res Commun ; 581: 20-24, 2021 12 03.
Article en En | MEDLINE | ID: mdl-34653674
ABSTRACT
Programmable DNA methylation is required for understanding of transcriptional regulation and elucidating gene functions. We previously reported that MMEJ-based promoter replacement enabled targeted DNA methylation in human cells. ssDNA-mediated knock-in has recently been reported to completely reduce random integrations. We speculated that by changing MMEJ-to ssDNA-based knock-in, targeted DNA methylation may be achieved through a hemimethylation-symmetric methylation pathway. We herein successfully developed a new system that enables the replacement of an unmethylated promoter with a methylated ssDNA promoter through ssDNA-based knock-in. A DNA methylation ratio of approximately 100% was achieved at the cancer-associated gene SP3 in HEK293 cells. The present results provide a promising framework for artificial epigenetic modifications.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: ADN de Cadena Simple / Metilación de ADN / Epigénesis Genética / Factor de Transcripción Sp3 / Edición Génica / Proteínas de Neoplasias Límite: Humans Idioma: En Revista: Biochem Biophys Res Commun Año: 2021 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: ADN de Cadena Simple / Metilación de ADN / Epigénesis Genética / Factor de Transcripción Sp3 / Edición Génica / Proteínas de Neoplasias Límite: Humans Idioma: En Revista: Biochem Biophys Res Commun Año: 2021 Tipo del documento: Article